Literature DB >> 986302

The value of adriamycin in overcoming resistance to methotrexate in tissue culture.

B T Hill, L A Price, J H Goldies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 986302     DOI： 10.1016/0014-2964(76)90160-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  8 in total

1.  Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.

Authors:  B T Hill; R D Whelan
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

2.  Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.

Authors:  B T Hill; L Y Dennis; X T Li; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Selective interactions of verapamil with anthraquinones in adriamycin-sensitive and -resistant murine and human tumour cell lines in vitro.

Authors:  E M Gibby; O Boyse; B T Hill
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  [Multidrug chemotherapy of osteogenic sarcoma (author's transl)].

Authors:  G Prindull
Journal:  Blut       Date:  1979-10

5.  Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.

Authors:  A Ramu; M Fridkin; R Steinherz
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro.

Authors:  B T Hill; L K Hosking; S A Shellard; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.

Authors:  B T Hill; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Comparative in vitro cytotoxicities of adriamycin (ADM) and 4'[(9-acridinyl)-amino] methane sulphon-m-anisidide (mAMSA)

Authors:  B T Hill; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.